author-photo

Ted Halmos

Boehringer Ingelheim

20

Papers

1083

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIs.

2016 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (12)
Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV

2014 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (11)
Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1

2014 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (104)
Multi-gram synthesis of a nucleotide-competing reverse transcriptase inhibitor

2013 Tetrahedron Letters
Show All
- Source
- Cite
- Save
Citations (0)
Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-Arylproline analogs

2013 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (6)
Identification of benzofurano[3,2-d]pyrimidin-2-ones, a new series of HIV-1 nucleotide-competing reverse transcriptase inhibitors

2013 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (9)
Discovery of a potent and selective noncovalent linear inhibitor of the hepatitis C virus NS3 protease (BI 201335).

2010 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (85)
The use of chemical double-mutant cycles in biomolecular recognition studies: application to HCV NS3 protease inhibitors.

2008 ChemMedChem
Show All
- Source
- Cite
- Save
Citations (13)
Novel azapeptide inhibitors of hepatitis C virus serine protease.

2004 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (32)
A systematic approach to the optimization of substrate-based inhibitors of the hepatitis C virus NS3 protease: discovery of potent and specific tripeptide inhibitors.

2004 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (110)